Cerus Inc (CERS): Bozor kapitallashuvining daromadga nisbati

Cerus Corp (CERS) brendining ramzi va logotipi

Cerus Corporation qon quyish markazlarida INTERCEPT tizimining joriy etilishini kengaytirish orqali global ustunlikka intilmoqda. GURU.Markets grafigidagi daromad baholash ko'rsatkichi 1.80 qiymati maqsadli daraja bo'lib xizmat qiladigan tendentsiyani aks ettiradi. Uning monopolist maqomi kompaniyaga sarf materiallari bo'yicha narxlarni belgilash imkoniyatini beradi, patogenlarni inaktivatsiya qilish jarayonlarining keng ko'lamli robotlashtirilishi esa inson omili tufayli yuzaga keladigan xatoliklarni minimallashtiradi.

Narxning daromadga nisbati: Cerus (CERS) 04.07.2022 - 15.11.2026 uchun

Cerus (CERS) kompaniyasi koʻrsatkichlari kesimi va tahlili

- kotirovkalar va tahlilchilar prognozi:
Kompaniyaning jamlanma tahliliyoti:Cerus Corp.
cerus.com seriyali mahsuloti

Fundamental yetakchilarni aniqlash uchun tahlilchilar P/S koeffitsiyentidan foydalanadilar, u bozor kapitalizatsiyasini yillik daromadga nisbatda solishtirib, bozorning sotuvlar birligi uchun to'lashga tayyor bo'lgan premiumini o'lchaydi. Cerus Corporation (CERS) holatida, ushbu sotuvlarga nisbatan narx baholashi boshqaruvning qon xavfsizligi tor sohasi doirasidagi kengayish strategiyasiga va tartibga soluvchi organlar tomonidan berilgan ruxsatnomalarni daromadga aylantirish qobiliyatiga bo'lgan ishonchni aks ettiradi.

Cerus Corporation raqobatchilari

Kapitalizatsiyaning sotish hajmiga nisbati ISRG|Danaher Corporation - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Becton Dickinson & Company BDX|STE - Narxning daromadga nisbati|West Pharmaceutical Services (WST) - Kapitalizatsiyaning daromadga nisbati|BAX: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Masimo|STVN (stevanatogroup.com) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati TFX (Teleflex Incorporated)|Narxning daromadga nisbati Merit Medical (MMSI)|Envista - Kapitalizatsiya va daromad nisbati|ICU Medical, Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati XRAY (Dentsply Sirona Inc)|LMAT - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti AtriCure Corp ATRC|staar.com (STAA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati ChromaDex Corporation|ZIMV (ZimVie Inc) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANGO (AngioDynamics)|Narxning daromadga nisbati Teknova (TKNO)|Monogram Orthopedics Inc. - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Sharps Technology, Inc. STSS|P/S multiplikatori InfuSystem Holdings INFU|UTMD: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KRMD (KORU Medical)|NYXH: P/S multiplikatori|MBOT (Microbot Medical, Inc) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PDEX|ZTEK: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ELUT|Milestone Scientific Inc. - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati NEXGEL, Inc. NXGL|Retractable Tech - Narxning daromadga nisbati|harvardbioscience.com - P/S multiplikatori|FEMY (Femasys Inc.) - Kapitalizatsiya va daromad nisbati|MHUA: P/S multiplikatori|Predictive Oncology Corp - Bozor kapitallashuvining daromadga nisbati|CJMB (Callan JMB) - P/S multiplikatori|Sotuvga nisbatan narx Atrion Corporation Inc. ATRI|P/S multiplikatori NURO